Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam versus sodium valproate for postoperative seizure prevention after brain tumor surgery
IRCT20261029071604N1Phase 4Not yet recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in brain neoplasm comparing Levetiracetam with Sodium Valproate (2 arms). Primary endpoints: Incidence of postoperative seizures, Frequency of seizure episodes and 1 more. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
levetiracetamvalproic acid
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on IRCT20261029071604N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20261029071604N1.